國立高雄大學圖資館 |

登入

回首頁

Radiopharmaceutical therapy

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Radiopharmaceutical therapyedited by Lisa Bodei, Jason S. Lewis, Brian M. Zeglis.
其他作者:	Bodei, Lisa.
出版者:	Cham :Springer International Publishing :2023.
面頁冊數:	xi, 564 p. :illustrations, digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	RadiopharmaceuticalsTherapeutic use.
電子資源:	https://doi.org/10.1007/978-3-031-39005-0
ISBN:	9783031390050$q(electronic bk.)

Radiopharmaceutical therapy
Radiopharmaceutical therapy[electronic resource] /edited by Lisa Bodei, Jason S. Lewis, Brian M. Zeglis. - Cham :Springer International Publishing :2023. - xi, 564 p. :illustrations, digital ;24 cm.

Preface -- Foreword -- Section 1. Fundamentals -- Chapter 1. Introduction: The Case for Endoradiotherapy -- Chapter 2. The History of Endoradiotherapy -- Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides -- Chapter 4. The Production of Therapeutic Radionuclides -- Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons -- Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides -- Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides -- Chapter 8. Dosimetry in Endoradiotherapy -- Section 2. Deeper Dives -- Chapter 9. Antibodies as Vectors for Endoradiotherapy -- Chapter 10. Case Study #1: 225Ac-Labeled IgG -- Chapter 11. Case Study #2: 131I-3F8 -- Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy -- Chapter 13. Peptides as Vectors for Endoradiotherapy -- Chapter 14. Case Study #4: LUTATHERA -- Chapter 15. Case Study #5: CXCR4 -- Chapter 16. Case Study #6: JR11 -- Chapter 17. Small Molecules as Vectors for Endoradiotherapy -- Chapter 18. Case Study #7: PSMA-617 -- Chapter 19. Case Study #8: 223RaCl3 -- Section 3. Special Topics -- Chapter 20. Auger Emitters in Endoradiotherapy -- Chapter 21. In Vivo Pretargeting -- Chapter 22. Theranostic Imaging and Endoradiotherapy -- Chapter 23. The Next Generation of Therapeutic Radionuclides -- Chapter 24. Artificial Intelligence and Machine Learning -- Chapter 25. The Regulatory Review of Radiotherapeutics: USA -- Chapter 26. The Regulatory Review of Radiotherapeutics: Europe -- Chapter 27. The Regulatory Review of Radiotherapeutics: Japan -- Chapter 28. Radiotherapeutics in the Nuclear Pharmacy -- Chapter 29. The Future.

This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird's-eye view, covering topics including the history of radiopharmaceutical therapy, the radiobiology of radiopharmaceutical therapy, and the radiopharmaceutical chemistry of both metallic and non-metallic radionuclides. The second section provides a more in-depth look at specific radiotherapeutics. Chapters include broader discussions of the different platforms for radiopharmaceutical therapy as well as more focused case studies covering individual radiotherapeutics. The third and final section explores a number of areas for further study, including medical physics, artificial intelligence, in vivo pretargeting, theranostic imaging, and the regulatory review process for radiotherapeutics. This book is the first of its kind and is useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology.

ISBN: 9783031390050$q(electronic bk.)

Standard No.: 10.1007/978-3-031-39005-0doiSubjects--Topical Terms:

939544
Radiopharmaceuticals
--Therapeutic use.

LC Class. No.: RS431.R34

Dewey Class. No.: 615.842

Radiopharmaceutical therapy
LDR:03847nmm a2200325 a 4500 001 653703
003 DE-He213
005 20231202090328.0
006 m d
007 cr nn 008maaau
008 240426s2023 sz s 0 eng d
020 $a 9783031390050$q(electronic bk.)
020 $a 9783031390043$q(paper)
024 7 $a 10.1007/978-3-031-39005-0 $2 doi
035 $a 978-3-031-39005-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RS431.R34
072 7 $a PSB $2 bicssc
072 7 $a SCI007000 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 615.842 $2 23
090 $a RS431.R34 $b R129 2023
245 0 0 $a Radiopharmaceutical therapy $h [electronic resource] / $c edited by Lisa Bodei, Jason S. Lewis, Brian M. Zeglis.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xi, 564 p. : $b illustrations, digital ; $c 24 cm.
505 0 $a Preface -- Foreword -- Section 1. Fundamentals -- Chapter 1. Introduction: The Case for Endoradiotherapy -- Chapter 2. The History of Endoradiotherapy -- Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides -- Chapter 4. The Production of Therapeutic Radionuclides -- Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons -- Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides -- Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides -- Chapter 8. Dosimetry in Endoradiotherapy -- Section 2. Deeper Dives -- Chapter 9. Antibodies as Vectors for Endoradiotherapy -- Chapter 10. Case Study #1: 225Ac-Labeled IgG -- Chapter 11. Case Study #2: 131I-3F8 -- Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy -- Chapter 13. Peptides as Vectors for Endoradiotherapy -- Chapter 14. Case Study #4: LUTATHERA -- Chapter 15. Case Study #5: CXCR4 -- Chapter 16. Case Study #6: JR11 -- Chapter 17. Small Molecules as Vectors for Endoradiotherapy -- Chapter 18. Case Study #7: PSMA-617 -- Chapter 19. Case Study #8: 223RaCl3 -- Section 3. Special Topics -- Chapter 20. Auger Emitters in Endoradiotherapy -- Chapter 21. In Vivo Pretargeting -- Chapter 22. Theranostic Imaging and Endoradiotherapy -- Chapter 23. The Next Generation of Therapeutic Radionuclides -- Chapter 24. Artificial Intelligence and Machine Learning -- Chapter 25. The Regulatory Review of Radiotherapeutics: USA -- Chapter 26. The Regulatory Review of Radiotherapeutics: Europe -- Chapter 27. The Regulatory Review of Radiotherapeutics: Japan -- Chapter 28. Radiotherapeutics in the Nuclear Pharmacy -- Chapter 29. The Future.
520 $a This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird's-eye view, covering topics including the history of radiopharmaceutical therapy, the radiobiology of radiopharmaceutical therapy, and the radiopharmaceutical chemistry of both metallic and non-metallic radionuclides. The second section provides a more in-depth look at specific radiotherapeutics. Chapters include broader discussions of the different platforms for radiopharmaceutical therapy as well as more focused case studies covering individual radiotherapeutics. The third and final section explores a number of areas for further study, including medical physics, artificial intelligence, in vivo pretargeting, theranostic imaging, and the regulatory review process for radiotherapeutics. This book is the first of its kind and is useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology.
650 0 $a Radiopharmaceuticals $x Therapeutic use. $3 939544
650 1 4 $a Biochemistry. $3 188609
650 2 4 $a Cancer Therapy. $3 915060
650 2 4 $a Radiation Oncology. $3 920157
650 2 4 $a Cancer Imaging. $3 277241
650 2 4 $a Nuclear Chemistry. $3 276243
700 1 $a Bodei, Lisa. $3 964396
700 1 $a Zeglis, Brian Matthew. $3 964398
700 1 $a Lewis, Jason. $3 964397
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-39005-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)